ResMed Backtesting

ResMed Inc -- USA Stock  

USD 98.43  0.25  0.25%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of ResMed Inc and determine expected loss or profit from investing in ResMed over given investment horizon. Additionally take a look at ResMed Hype Analysis, ResMed Correlation, ResMed Valuation, ResMed Volatility as well as analyze ResMed Alpha and Beta and ResMed Performance
 Time Horizon     30 Days    Login   to change

ResMed 'What if' Analysis

February 19, 2018
No Change 0.00  0.0%
In 31 days
March 21, 2018
If you would invest  0.00  in ResMed on February 19, 2018 and sell it all today you would earn a total of 0.00 from holding ResMed Inc or generate 0.0% return on investment in ResMed over 30 days. ResMed is related to or competes with DexCom, Boston Scientific, Cooper Companies, Quest Diagnostics, DENTSPLY SIRONA, and . ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that ...

ResMed Upside/Downside Indicators


ResMed Market Premium Indicators

ResMed Inc lagged returns against current returns

 Current and Lagged Values 

ResMed regressed lagged prices vs. current prices

 Current vs Lagged Prices 

ResMed Inc Backtested Returns

Macroaxis considers ResMed not too risky given 1 month investment horizon. ResMed Inc maintains Sharpe Ratio (i.e. Efficiency) of 0.3403 which implies ResMed Inc had 0.3403% of return per unit of risk over the last 1 month. Our philosophy towards forecasting volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for ResMed Inc which you can use to evaluate future volatility of the company. Please employ ResMed Inc Coefficient Of Variation of 419.49, Semi Deviation of 0.5074 and Risk Adjusted Performance of 0.2557 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100 ResMed holds performance score of 22. The organization holds Beta of -0.1908 which implies as returns on market increase, returns on owning ResMed are expected to decrease at a much smaller rate. During bear market, ResMed is likely to outperform the market.. Although it is vital to follow to ResMed Inc current trending patterns, it is good to be conservative about what you can actually do with the information regarding equity existing price patterns. The philosophy towards forecasting future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing ResMed Inc technical indicators you can presently evaluate if the expected return of 0.2866% will be sustainable into the future. Please employ ResMed Inc Expected Short fall, and the relationship between Value At Risk and Daily Balance Of Power to make a quick decision on weather ResMed historical price patterns will revert.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation 0.82 

Very good predictability

ResMed Inc has very good predictability. Overlapping area represents the amount of predictability between ResMed time series from February 19, 2018 to March 6, 2018 and March 6, 2018 to March 21, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ResMed Inc price movement. The serial correlation of 0.82 indicates that around 82.0% of current ResMed price fluctuation can be explain by its past prices.
Correlation Coefficient 0.82
Spearman Rank Test 0.58
Price Variance 1.05
Lagged Price Variance 1.29

ResMed Lagged Returns

 Regressed Prices 

ResMed Performance vs DOW

The median price of ResMed for the period between Mon, Feb 19, 2018 and Wed, Mar 21, 2018 is 96.4 with a coefficient of variation of 2.18. The daily time series for the period is distributed with a sample standard deviation of 2.1, arithmetic mean of 96.36, and mean deviation of 1.79. The Stock received some media coverage during the period.
 Price Growth (%)  
Shell Asset Management Co. Sells 12173 Shares of ResMed Inc.02/27/2018
These Two Stocks in Motion ResMed Inc. , Apricus Biosciences...03/20/2018